United States· US:0220-1248_1def1d50-a9e3-9db3-e063-6294a90aa3c2
Chamomilla
A medicinal product containing matricaria chamomilla, registered in United States by Boiron.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MATRICARIA CHAMOMILLA
- Manufacturer
- Boiron
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110220-1248-41
- ndc1102201248419 [hp_C] in 1 TUBE (0220-1248-41)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Matricaria chamomilla in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b8014190-0452-4f6b-b6a7-2a77e39785de GET /v1/drugs/b8014190-0452-4f6b-b6a7-2a77e39785de?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "9",
"substance": "MATRICARIA CHAMOMILLA",
"productndc": "0220-1248",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/9[hp_C]",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about matricaria chamomilla.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.